TMTC2 rs7976168: Longevity Associations and Meaning
rs7976168 is an intronic single nucleotide polymorphism located in the TMTC2 gene on chromosome 12. Genome-wide association studies evaluating centenarians and exceptionally long-lived individuals have identified this variant as being enriched in extreme longevity cohorts. While carrying the associated common allele correlates with survival to the oldest ages, its effect size is modest and represents only one component in the complex genetics of human lifespan.
What each genotype means
Typical longevity-associated genotype
This genotype represents the more common state for this variant in many populations. Research has identified this specific genetic location in TMTC2 as being associated with extreme longevity, though the exact biological mechanism remains a subject of ongoing study.
This genotype is common in European populations, where the minor allele frequency for this variant is approximately 0.30 to 0.35.
Longevity-associated variant carrier
Carrying one copy of the G allele at this position in the TMTC2 gene has been observed in studies of individuals with extreme longevity. While this variant is linked to longevity-associated cohorts, it is not a diagnostic marker and should be viewed as one of many factors influencing healthspan.
This heterozygous genotype is frequently observed in European populations, consistent with the reported minor allele frequency of 0.30 to 0.35.
Enriched longevity-associated genotype
This genotype involves two copies of the G allele, which has been identified in research as having an enriched frequency in cohorts of centenarians. This suggests a potential association with extreme longevity, though further research is required to fully understand the functional role of TMTC2 in human aging.
This genotype is present in a significant portion of the population, reflecting the common nature of this variant in European ancestry groups.
Genomic Location and Variant Characteristics
The single nucleotide polymorphism rs7976168 is mapped to chromosome 12 within an intronic region of the TMTC2 gene. Because it resides in non-coding intronic DNA, it does not directly alter the amino acid sequence of the resulting TMTC2 protein. Instead, non-coding genetic variants frequently exert biological effects by influencing gene regulation, splicing patterns, or expression levels in specific cell types. In dbSNP and reference assemblies, rs7976168 represents a transition between two common alleles. Research analyzing linkage disequilibrium and surrounding regulatory elements suggests that rs7976168 may act as a marker for nearby regulatory variation or operate in tandem with adjacent haplotypic blocks that influence local transcript expression.
The Biological Role of the TMTC2 Gene
The TMTC2 gene, short for transmembrane and tetratricopeptide repeat containing 2, encodes an integral membrane protein localized primarily to the endoplasmic reticulum. Members of the TMTC family participate in cellular protein processing, including protein O-mannosylation, as well as the regulation of calcium homeostasis and endoplasmic reticulum stress responses. Although TMTC2 has been studied in contexts ranging from sensory biology to human nonsyndromic hearing loss, its exact biochemical contribution to systemic aging remains an area of ongoing discovery. Proper protein folding, cellular stress resilience, and calcium handling are foundational processes in cellular maintenance, which researchers hypothesize may underlie the gene's statistical link to healthy aging phenotypes.
Evidence from Extreme Longevity Cohorts
The primary clinical interest in rs7976168 stems from large-scale meta-analyses of genome-wide association studies (GWAS) focusing on extreme longevity (individuals surviving beyond the 99th survival percentile, such as centenarians). In discovery cohorts, the major allele showed an increased frequency among long-lived cases compared to younger control groups, rising from roughly 64-67% in standard controls to 69-72% in centenarians. Survival curve analyses stratified by genotype have suggested a survival selection mechanism: carriers of the alternate non-longevity allele showed earlier declines in survival curves, resulting in an enrichment of the longevity-associated allele in the oldest old. While statistically significant across combined cohorts, the overall evidence strength is considered moderate because longevity is an exceptionally polygenic trait influenced by thousands of minor loci.
Population Frequency and Ancestral Distribution
The distribution of rs7976168 alleles varies across world populations, with the majority of published longevity associations evaluated primarily in cohorts of European ancestry. In European populations, the minor allele frequency is approximately 0.30 to 0.35, meaning that the majority of individuals carry at least one copy of the common longevity-associated allele. In other ancestral backgrounds, including African, East Asian, and South Asian populations, allele frequencies can differ markedly due to historical population bottlenecks and genetic drift. Consequently, researchers caution against extrapolating statistical odds ratios from European centenarian studies directly to individuals of diverse or non-European ancestries without ancestry-specific replication.
What You Can and Cannot Conclude
Discovering your rs7976168 genotype provides educational insight into one genetic marker evaluated in aging research, but it cannot predict an individual lifespan. Longevity is a multifaceted trait shaped overwhelmingly by non-genetic factors—such as nutrition, physical activity, cardiovascular health, access to healthcare, and environmental exposures—alongside hundreds of small-effect genetic variants. Carrying the longevity-associated genotype does not guarantee an extended lifespan or confer immunity to chronic disease, nor does carrying the alternate genotype imply premature mortality. Consumers should use genotype data solely to understand human genetic diversity rather than attempting to direct personal medical care, lifestyle interventions, or diagnostic assessments.
How common is this variant?
The minor allele frequency for rs7976168 is roughly 0.30 to 0.35 in European populations, making the longevity-associated variant the predominant major allele. Frequencies may vary significantly among other global ancestral groups, where extreme longevity studies for this locus remain less characterized.
Frequently asked questions
Does having the TMTC2 rs7976168 longevity allele mean I will live to 100?
No. Genetic variants linked to longevity each contribute only a fraction of a percent to overall lifespan variation. Environmental factors, lifestyle habits, and hundreds of other genes play far larger roles in determining individual lifespan.
What is the biological function of the TMTC2 gene?
TMTC2 encodes an endoplasmic reticulum protein involved in cellular protein O-mannosylation and cellular stress responses. While researchers suspect its role in maintaining cellular homeostasis may relate to healthy aging, its direct biological mechanism in longevity remains under active study.
Why is the common allele considered the longevity allele?
In genetic studies of centenarians, the common allele appeared at higher rates in very old individuals (69-72%) compared to younger population controls (64-67%). Researchers hypothesize that carriers of the alternate allele experienced slightly higher mortality earlier in life, leading to survivor enrichment.
Can doctors test for rs7976168 to assess health risks?
No, clinical laboratories do not test for rs7976168 for diagnostic or prognostic purposes. Because the variant's effect size is small and it is not clinically actionable, it is primarily of academic interest in population genomics.
Sources & further reading
Educational information only, last refreshed 9/4/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs7976168?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29